Clinical Professor
Research Interests:

My focus in cerebrovascular disease has been in the areas of stroke prevention, acute stroke management, thrombolysis, antithrombotic therapies, and neuroprotection strategies.  I have been extensively involved in the planning, organization, and conduct of clinical trials.

B.Me.Sc University of Alberta
MD University of Alberta
FRCP(C) Royal College of Physicians & Surgeons of Canada Emergency Medicine
FRCP(C) Royal College of Physicians & Surgeons of Canada Neurology
FACEP American Boards of Emergency Medicine Emergency Medicine
Recent Publications:
  • Mehdiratta M, Woolfenden AR, Chapman KM, Johnston DC, Schulzer M, Beckman J, Teal PA.  Reduction in IV t-PA Door to Needle Times using an Acute Stroke Triage Pathway. Can J. Neurol. Sci. 33:214-216, 2006.
  • Mehdiratta M, Woolfenden AR, Johnston DCC, Chapman KM, Teal PA.   Reduction of IV tPA Door to Needle Times with an Acute Stroke Triage Pathway. Canadian J of Neurol Sciences 2006;33:214-16.
  • Singh R, Graeb DJ, Teal, PA.  Fatal Cardiac Rupture During Intra-Arterial Thrombolytic  Therapy for Acute Embolic Stroke in a Patient with Recent Myocardial Infarction.  AJNR.   In Press.
  • Teal PA, Norris JW.  Asymptomatic Disease of the Carotid Arteries – Medical Considerations.  In Stroke:  Pathophysiology Diagnosis, and Management.  Barnett, HJM et al (ed).  3rd Edition.  (in press).
  • M Mehdiratta, C Murphy, A Al-Harthi, P Teal.  Myocardial Infarction Following tPA for Acute Stroke.  Canadian Journal of Neurological Sciences.  2007; 34(4):  417-20.
  • Woolfenden AR, Wade NK, Tang P, Chalmers A, Reid G, Teal PA. Uveitis associated with Primary Angiitis of the Central Nervous System. Can J Neurol Sci. 2007; 34: 81-3.
  • Woolfenden AR, Wade NK, Tang P, Clamers A, Reid G, Teal PA.  Uveitis Associated with Primary Angiitis of the Centreal Nervous System. Can J. Neurol. Sci.  2007;34:81-83.
  • Adams HP, Effron MB,Torner J, Davalos A, Frayne J, Teal Philip, Lerclerc, J et al.  Emergency administration of Abciximab for treatment of patients with acute ischemic stroke:  Results of an International Phase III Trial.  Stroke 2008;39:87-89.
  • Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P.  Antithrombotic and thrombolytic therapy for ischemic stroke:  American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Addition)  CHEST 2008;133:630-669S.
  • Diener HC, Sacco RL, Yusef S, et al including Teal PA . Effects of aspirin plus extended-release dipyridamole versus Clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurology Sept 2008;7:875-84.
  • Sacco RL, Diener HC, Yusuf S, et al including Teal P. Aspirin and Extended Released Dypyridaomole vs clopidogrel for recurrent stroke.  N Eng J Med 2008;359:1238-51.
  • Yusuf S, Diener HC, Sacco RL et al including Teal, P. Telmisartan to prevent recurrent Stroke and cardiovascular events.  N Engl J Med 2008;359:1225-37.